Adam Rabalski

Adam Rabalski

Company: Scorpion Therapeutics

Job title: Senior Scientist II Chemical Biology & Proteomics

Seminars:

Design Principles of Covalent Fragment Libraries 9:00 am

Targeted covalent inhibition has renewed the landscape for the undruggable genome and previously hard to drug targets. There are significant advantages of covalent fragment based drug discovery, and this now represents a promising methodology to discover and validate novel targets. This session will consider the design principles behind the development of a covalent fragment library,…Read more

day: Pre-Conference Day Track A

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.